Frost & Sullivan is conducting a survey to better understand the changing industry dynamics and evolving end-user preferences in the Regenerative Medicine (RM) Cell Therapy Market. The Cell Therapy Market segment consists of “living cells" that are used to replace damaged or diseased cells or tissues, induce an immune response, deliver genetic and molecular therapies, used as biomarkers, or in drug discovery or toxicity testing. This survey seeks to identify the most prominent market and technology trends that currently impact the RM Cell Therapy industry, based on responses from experts who are actively involved in the World Stem Cell Summit 2014.
